Publications 2019

1. BONNAFOUS P, MARLET J, GAUDY-GRAFFIN C, GAUTHERET-DEJEAN A. Need for a better characterization of HHV-6 infections and associated clinical impacts. Am J Transplant. 2019 Jan;19(1):304-305
 
2.  STEFIC K, BOUVIN-PLEY M, ESSAT A, VISDELOUP C, MOREAU A, GOUJARD C, CHAIX ML, BRAIBANT M, MEYER L, BARIN F. Sensitivity to broadly neutralizing antibodies of recently transmitted HIV-1 clade CRF02_AG viruses with a focus on evolution over time. J Virol. 2018, in press
 
3. ROINGEARD P, RAYNAL P-I, EYMIEUX S, BLANCHARD E. Virus detection by transmission electron microscopy: still useful for diagnosis and a plus for biosafety. Rev Med Virol 2019 ; 29 : e2019.
 
4. APPOURCHAUX R, DELPEUCH M, ZHONG LI, BURLAUD-GAILLARD J, TARTOUR K, SAVIDIS G, BRASS A, ETIENNE L, ROINGEARD P, CIMARELLI A.  Functional mapping of regions involved in the negative imprinting of virion particles infectivity and in target cell protection by the interferon-induced transmembrane protein 3 (IFITM3) against HIV-1 : evidence in favour of a single antiviral mechanism. J Virol 2019 ; 93 : e01716-18.
 
5. STEFIC K, BOUVIN-PLEY M, ESSAT A, VISDELOUP C, MOREAU A, GOUJARD C, CHAIX ML, BRAIBANT M, MEYER L, BARIN F. Sensitivity to broadly neutralizing antibodies of recently transmitted HIV-1 clade CRF02_AG viruses with a focus on evolution over time. J Virol 2019 ; 93 : e01492-18.
 
6. BOUVIN-PLEY M, BERETTA M, MOREAU A, ROCH E, ESSAT A, GOUJARD C, CHAIX ML, MOIRÉ N, MARTIN L, MEYER L, BARIN F, BRAIBANT M. Evolution of the envelope glycoprotein of HIV-1 clade B towards higher infectious properties over the course of the epidemic. J Virol 2019 ; 93 : e01171-18.
 
7. TODESCO E, WIRDEN M, CALIN R, SIMON A, SAYON S, BARIN F, KATLAMA C, CALVEZ V, MARCELIN AG, HUÉ S. Caution is needed in interpreting HIV transmission chains by ultra-deep sequencing. AIDS 2019 ; 33 : 691-699.
 
8. LAROCHETTE V, MIOT C, POLI C, BEAUMONT E, ROINGEARD P, FICKENSCHER H, JEANNIN P,
DELNESTE Y. IL-26, a cytokine with roles in extracellular DNA-induced inflammation and microbial defense.  Front Immunol 2019 ; 10 : e204.
 
9. ASSOUMOU L, BOCKET L, PALLIER C, GRUDE M, AIT-NAMANE R, IZOPET J, RAYMOND S, CHARPENTIER C, VISSEAUX B, WIRDEN M, TRABAUD MA, LE GUILLOU-GUILLEMETTE H, ALLAOUI C, HENQUELL C, KRIVINE A, DOS SANTOS G, DELAMARE C, BOUVIER-ALIAS M, MONTES B, FERRE V, DE MONTE A, SIGNORI-SCHMUCK A, MAILLARD A, MORAND-JOUBERT L, TUMIOTTO C, FAFI-KREMER S, AMIEL C, BARIN F, MARQUE-JUILLET S, COURDAVAULT L, VALLET S, BEBY-DEFAUX A, DE ROUGEMONT A, FENAUX H, AVETTAND-FENOEL V, ALLARDET-SERVENT A, PLANTIER JC, PEYTAVIN G, CALVEZ V, CHAIX ML, DESCAMPS D. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. J Antimicrob Chemother 2019; 74: 1417-1424.
 
10. DELAGREVERIE HM, GRUDE M, LAMBERT-NICLOT S, NERE ML, JADAND C, LEPORT C, RAFFI F, GHISLAIN M, GOUJARD C, MEYER L, CALVEZ V, KATLAMA C, FLANDRE P, BARIN F, DELAUGERRE C. Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants. J Antimicrob Chemother 2019 ; 74 :1389-1394.
 
11. BARIN F, BRAIBANT M. HIV-1 antibodies in prevention of transmission. Curr Opin HIV AIDS 2019, 4: 273-278.
 
12. VAUX S, CHEVALIEZ S, SABONI L, SAUVAGE C, SOMMEN C, BARIN F, ALEXANDRE A, JAUFFRET-ROUSTIDE M, LOT F, VELTER A. Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015. BMC Infect Dis 2019, 19: e315.
 
13. BOYER A, DRENEAU J, DUMANS A, BURLAUD-GAILLARD J, BULL-MAURER A, ROINGEARD P, MEUNIER JC. Endoplasmic Reticulum Detergent-Resistant Membranes Accommodate Hepatitis C Virus Proteins for Viral Assembly. Cells 2019, 8: e487.
 
14. RAT V, SEIGNEURET F, BURLAUD-GAILLARD J, LEMOINE R, HOURIOUX C, ZOULIM F, TESTONI B, MEUNIER JC, TAUBER C, ROINGEARD P, DE ROCQUIGNY H. BAY41-4109-mediated aggregation of assembled and misassembled HBV capsid in cells revealed by electron microscopy. Antiviral Research 2019, 169: e104557.
 
15. PLISSONNIER ML, COTTAREL J, PIVER E, KULLOLLI M, CENTONZE FG, PITTERI S, FARHAN H, MEUNIER JC, ZOULIM F, PARENT R. LARP1 binding to hepatitis C virus particles is correlated with intracellular retention of viral infectivity. Virus Res 2019 ; e197679.
 
16. MEERTENS L, HAFIRASSOU ML, BONNET-MADIN L, BRUGIER A, KRILL V, SIMON-LORIERE S, BURLAUD-GAILLARD J, DOYEN C, LABEAU A, PEZZI L, DE LAMBALLERIE X, KÜMMERER BM, VIDALAIN PO, BERTEAND-LEGOUT A, BEN YAOU R, BONNE G, BENKIRANE M, ROINGEARD P, DELAUGERRE C, AMARA A. FHL1A is a major host factor for Chikungunya virus infection. Nature 2019 ; 574 : 259-263.
 
17. MONEL B, RAJAH MM, HAFIRASSOU ML, SID-AHMED S, BURLAUD-GAILLARD J, ZHU P-P, NEVERS Q, BUCHRIESER J, PORROT F, MEUNIER C, AMRAOUI S, CHAZAL M, SALLES A, JOUVENET N, ROINGEARD P, BLACKSTONE C, AMARA A, SCHWARTZ O. The Atlastin ER-shaping proteins facilitate Zika virus replication. J Virol 2019 ; 23: e1047-19.
 
18. LÉON L, PILLONEL J, JAUFFRET-ROUSTIDE M, BARIN F, LE STRAT Y. Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey). Epidemiol Infect 2019 ; 147: e220.
 
19. STEFIC K, BOUVIN-PLEY M, BRAIBANT M, BARIN F. Impact of HIV-1 diversity on its sensitivity to neutralization. Vaccines 2019 ; 7: e74.
 
20. PASTOR F, HERRSCHER C, PATIENT R, EYMIEUX S, MOREAU A, BURLAUD-GAILLARD J, SEIGNEURET F, DE ROCQUIGNY H, ROINGEARD P, HOURIOUX C. Direct interaction between hepatitis B virus core and envelope protein analyzed in a cellular context. Sci Rep 2019 ; 9: e16178.
 
21. BROUARD C, SABONI L, GAUTIER A, CHEVALIEZ S, RAHIB D, RICHARD JB, BARIN F, LARSEN C, SOMMEN C, PILLONEL J, DELAROCQUE-ASTAGNEAU E, LYDIÉ N, LOT F. HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy. BMC Infect Dis 2019 ;19: 896.
 
22. AMBLARD F, BOUCLE S, BASSIT L, COX B, SARI O, TAO S, CHEN Z, OZTURK T, VERMA K, RUSSELL O, RAT V, DE ROCQUIGNY H, FIQUET O, BOUSSAND M, DI SANTO J, STRICK-MARCHAND H, SCHINAZI RF. Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses in Vitro and in Humanized Mice. Antimicrob Agents Chemother 2019 ; in press
 
23. STEFIC K, GUINARD J, PEYTAVIN G, SABONI L, SOMMEN C, SAUVAGE C, LOT F, LAPERCHE S, VELTER A, BARIN F. Screening for Human Immunodeficiency Virus infection using a fourth-generation antigen/antibody assay and dried blood spots: in depth analysis of sensitivity and performance assessment in a cross-sectional study. J Clin Microbiol 2019 ; in press
 
24. VISSEAUX B, ASSOUMOU L, MAHJOUB N, GRUDE M, TRABAUD MA, RAYMOND S, WIRDEN M, MORAND-JOUBERT L, ROUSSEL C, MONTES B, BOCKET L, FAFI-KREMER S, AMIEL C, DE MONTE A,STEFIC K, PALLIER C, TUMIOTTO C, MAILLARD A, VALLET S, FERRE V, BOUVIER-ALIAS M, DINA J, SIGNORI-SCHMUCK A, CARLES MJ, PLANTIER JC, MEYER L, DESCAMPS D, CHAIX ML. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence ? J Antimicrob Chemother 2019 ; in press
 
25. BAILLY E, STEFIC K, GATAULT P, MIQUELESTORENA-STANDLEY E, MACHET MC, BARBET C, BARIN F, HALIMI JM. Prevention of parvovirus B19-induced repetitive acute kidney failure by subcutaneous immunoglobulins. Fundam Clin Pharmacol 2019 ; in press
 
26. HERZOG K, BANDIERA S, PERNOT S, FAUVELLE C, JUHLING F, WEISS A, BULL A, DURAND SC, CHANE-WOON-MING B, PFEFFER S, MERCEY M, LERAT H, MEUNIER JC, RAFFELSBERGER W, BRINO L, BAUMERT T, ZEISEL M. Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity. Gut 2019, in press